StockData
QuidelOrtho Corp logo

QuidelOrtho Corp (QDEL) stock

QDELNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends January 1
Financials through Q3 FY2026, quarter ended Sep 27, 2026Last filing: 10-Q on Nov 4, 2026Score 6/3067% below fair value
$8.32−0.60 (-6.73%)

Close on Nov 20, 2026Market cap $570.55MP/E –Yield –

QuidelOrtho net income

Net income is the profit left for shareholders after every expense, interest and tax.

QuidelOrtho's net income for the twelve months ending Sep 27, 2026 was -$369.20M. For fiscal 2025 it was -$1.13B. The highest annual figure on record is $810.30M in fiscal 2020.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 28, 2025-$1.13B–
FY2024Dec 29, 2024-$2.05B–
FY2023Dec 31, 2023-$10.10M-101.8%
FY2022Jan 1, 2023$548.70M-22.1%
FY2021Jan 2, 2022$704.20M-13.1%
FY2020Jan 3, 2021$810.30M–

Quarterly net income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 27, 2026-$53.80M–
Q2 FY2026Jun 28, 2026-$92.90M–
Q1 FY2026Mar 29, 2026-$91.80M–
Q4 FY2025Dec 28, 2025-$130.70M–
Q3 FY2025Sep 28, 2025-$733.00M–
Q2 FY2025Jun 29, 2025-$255.40M–
Q1 FY2025Mar 30, 2025-$12.70M–
Q4 FY2024Dec 29, 2024-$178.40M-2648.6%
Q3 FY2024Sep 29, 2024-$19.90M–
Q2 FY2024Jun 30, 2024-$147.70M–
Q1 FY2024Mar 31, 2024-$1.71B-3595.9%
Q4 FY2023Dec 31, 2023$7.00M-76.9%
Q3 FY2023Oct 1, 2023-$12.70M-166.1%
Q2 FY2023Jul 2, 2023-$53.20M-375.6%
Q1 FY2023Apr 2, 2023$48.80M-89.8%
Q4 FY2022Jan 1, 2023$30.30M-89.6%
Q3 FY2022Oct 2, 2022$19.20M-91.1%
Q2 FY2022Jul 3, 2022$19.30M+1.0%
Q1 FY2022Apr 3, 2022$479.90M+169.5%
Q4 FY2021Jan 2, 2022$291.30M–
Q3 FY2021Oct 3, 2021$215.70M–
Q2 FY2021Jul 4, 2021$19.10M–
Q1 FY2021Apr 4, 2021$178.10M–

More QuidelOrtho figures

See a number that looks wrong?